News Posts List
Drug combo marks new advance in immunotherapy
05/16/2013
Bristol released preliminary data from the early-stage trial on Wednesday, with more detailed results expected to highlight the American Society of Clinical Oncology's annual meeting in Chicago that starts at the end of the month.
Progression-Free Survival Data for Investigational Afatinib and Nintedanib
05/16/2013
Nintedanib is being evaluated in various solid tumors – including advanced NSCLC, ovarian cancer, liver cancer (hepatic cell carcinoma), kidney cancer (renal cell carcinoma) and colorectal cancer.
Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology
05/16/2013
Development program for nivolumab now includes seven potentially registrational trials in non-small-cell lung cancer, advanced melanoma and renal cell carcinoma.
Jennerex Announces Science Translational Medicine Publication
05/16/2013
Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced the publication of data demonstrating the ability of its lead product-candidate, Pexa-Vec (JX-594, pexastimogene devacirepvec) to induce functional anti-cancer immunity, both in patients with diverse solid tumor types and in animal models.
Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
05/16/2013
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar® (sorafenib) tablets, Stivarga® (regorafenib) tablets and the recently U.S. Food and Drug Administration (FDA) approved product Xofigo® (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 31 – June 4, in Chicago, IL (USA). These data showcase Bayer's commitment to developing treatments for difficult-to-treat cancers.
Roche immunotherapy shows response over range of cancers
05/16/2013
An experimental Roche Holding AG drug that helps the immune system attack tumors was well tolerated and demonstrated an impressive effect against a variety of cancers, according to preliminary trial results released on Wednesday.
Yourwellness Magazine Follows Up Statins and Kidney Cancer Study
05/16/2013
A new study, presented this week at the annual meeting of the American Urological Association in San Diego, has found that statins may be able to fight kidney cancer.
Eat garlic and onions every day for optimum heart health, immunity, cancer prevention
05/16/2013
Garlic and onions, two of the most popular flavoring accompaniments in American cooking today, not only serve a culinary purpose to make foods taste more flavorful. These two popular parts of the American diet actually contain a plethora of health benefits within.
NCI Video Series: Understanding Your Cancer Prognosis
05/16/2013
"Prognosis is an estimate of the likely outcome,or course, of a disease."
Join Facebook's Largest Open Group Dedicated to Helping Families Dealing With Kidney Cancer
05/16/2013
The Kidney Cancer Friends Facebook Group is a forum for open discussion of kidney cancer (subject to whatever limitations Facebook chooses to impose).
News Feed